Your browser doesn't support javascript.
loading
Successful reconstitution of leukocyte adhesion defect after umbilical cord blood stem cell transplant.
Chakraborty, Sushmita; Gupta, Devika; Thakral, Deepshi; Bakhshi, Sameer; Kumar, Prabin; Kabra, Sushil Kumar; Lodha, Rakesh; Mitra, Dipendra Kumar.
Afiliación
  • Chakraborty S; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
  • Gupta D; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
  • Thakral D; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
  • Bakhshi S; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Kumar P; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
  • Kabra SK; Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Lodha R; Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Mitra DK; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
Cent Eur J Immunol ; 45(1): 117-121, 2020.
Article en En | MEDLINE | ID: mdl-32425689
Leukocyte adhesion deficiencies (LADs) are a type of primary immunodeficiencies characterized by delayed detachment of the umbilical cord, impaired wound healing, leukocytosis, and recurrent infections. The disease is caused by genetic defects affecting different steps in the process of leukocyte adhesion cascade such as rolling, integrin activation, and adhesion of leukocytes, resulting in the impairment of leukocyte trafficking. Till date, three types of LAD have been documented: type I, II and III. Type I LAD is caused by congenital defect in the ß2 integrin receptor complex CD11/CD18 on the cell surface of leukocytes, which results in impaired leukocytes connection to endothelial cells and migration. Type II LAD is caused by defect in the fucose metabolism resulting in the absence of fucosylated selectin ligands on neutrophils and impaired rolling phase of the leukocyte adhesion cascade. Type III LAD is caused by mutations in the kindlin-3 gene resulting in defective integrin activation. In this article, we present a review of literature for type I LAD, and successful treatment of patient using umbilical cord blood stem cell transplantation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cent Eur J Immunol Año: 2020 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cent Eur J Immunol Año: 2020 Tipo del documento: Article País de afiliación: India
...